NL-OMON56580招募中2 期
Two-fraction Ultra-hypofractionated Radiotherapy with Focal Boost for low- and intermediate risk, localized prostate cancer (TURBO):phase II, randomized controlled clinical trial - TURBO
niversitair Medisch Centrum Utrecht0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Age >=18 years
- •Histopathological confirmation of prostate adenocarcinoma requiring radical
- •Intraprostatic tumor visible and delineable on diagnostic imaging
- •EAU intermediate risk prostate cancer
- •o PSA < 20 ng/ml
- •o Gleason score <= 7
- •o cT1c-cT2b/iT3a (non-bulky, < 20mm)
- •Written informed consent
- •Informed consent to share medical data and fill out quality of life
- •questionnaires in the MOMENTUM study.
排除标准
- •Contraindication to MRI (e.g., pacemaker)
- •IPSS 15 or higher
- •Prostate volume > 80 cc
- •Comorbidities which predispose to significant toxicity (e.g., inflammatory
- •bowel disease)
- •Metal pelvic implants which cause artefact on MR-imaging sequences (e.g.,
- •total hip replacement)
- •Previous radical prostatectomy
- •Previous pelvic radiotherapy
- •Previous invasive malignancy within the last 5 years, excluding basal cell
- •carcinoma of the skin
研究者
相似试验
已完成
1 期
Hypofractionated radiotherapy for low and intermediate-risk prostate cancer using robot-tracking stereotactic radiotherapy -phase I/II clinical trialprostate cancerJPRN-UMIN000014328Osaka University Graduate School of Medicine75
招募中
3 期
Standard moderately hypofractionated radiotherapy vs. ultra-hypofractionated focal lesion ablative microboost in prostate cancer, Hypo-FLAME 3.010038597prostate cancerNL-OMON56327Antoni van Leeuwenhoek Ziekenhuis352
招募中
2 期
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer PatientsRadiotherapy Side EffectBreast CancerNCT05762900Cancer Institute and Hospital, Chinese Academy of Medical Sciences65
已完成
2 期
Intensity-modulated, hypofractionated radiotherapy with scanning beam protons for locally advanced carcinoma of the prostate and localized carcinoma of the prostate with risk factors - a phase II studyC61Malignant neoplasm of prostateDRKS00011912Westdeutsches Protonentherapiezentrum Essen (WPE)133
招募中
不适用
Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate CancerProstate AdenocarcinomaLocalized Prostate CarcinomaProstate CancerNCT06518226UMC Utrecht160